MedTrace Logo

Tobacco Smoke and Lead Exposure During Pregnancy

NCT00514280 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2017-07-02

No results posted yet for this study

Summary

This study will test whether a short interview session about lead and secondhand tobacco smoke can help pregnant women reduce their exposure to lead and secondhand smoke. Both lead and secondhand tobacco smoke can cause problems with a pregnancy. The best way to prevent exposure to lead and secondhand tobacco smoke is to recognize the sources and avoid them.

Non-smoking African-American and Hispanic pregnant women between 18 and 49 years of age who live in Washington, D.C. may be eligible for this study.

Participants are randomly assigned to one of two study groups. Both groups have a 30-minute one-on-one session with a member of the study staff. The content of the session differs between groups. In addition, all women undergo the following tests and procedures:

* Answer questions about themselves, their pregnancies, diet, home and smokers in the home.
* Requested to provide permission to obtain medical records of children older than 12 months of age who have ever been seen at Children's National Medical Center.
* Blood draws at least four times during the study: at the time of enrollment, during the second trimester of the pregnancy, during the third trimester, and at the time of delivery. Up to three optional blood samples may also be requested, one during each trimester of the pregnancy. Blood samples are used to measure lead, cotinine (a chemical the body makes out of nicotine) and hematocrit (a test for anemia).
* Collection of umbilical cord blood at the time of delivery.
* Answer questions after the delivery about the patient's health, the delivery and the baby.

Conditions

  • Lead Exposure in Pregnant Women
  • Tobacco Smoke Exposure Pregnant Women

Sponsors & Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    lead NIH

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-08-02
Completion
2011-05-11

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00514280 on ClinicalTrials.gov